Resources Space-Time Yield | Sunflower Application Note Oct 30, 2024read more Perfusion fermentation in the Daisy Petal™ bioreactor | Sunflower Application Note Jun 13, 2024read more Alternative hosts as the missing link for equitable therapeutic protein production Mar 11, 2021read more The unequal scramble for coronavirus vaccines – by the numbers | Nature Aug 22, 2020read more Expanding access to monoclonal antibody-based products: a global call to action | Wellcome and IAVI Aug 22, 2020read more The influence of domestic manufacturing capabilities on biologic pricing in emerging economies | Nature Biotechnology May 22, 2019read more Publications Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus May 1, 2021 Rapid optimization of processes for the integrated purification of biopharmaceuticals Mar 30, 2021 Development of a platform process for the production and purification of single‐domain antibodies Feb 22, 2021 “Right-sized” efficient multi-product manufacturing | NASEM Workshop on Technical & Regulatory Barriers to Innovations in Pharmaceutical Manufacturing Jun 8, 2020 On-demand manufacturing of clinical-quality biopharmaceuticals | Nature Biotechnology Oct 5, 2018 The yeast stands alone: the future of protein biologic production | Current Opinion in Biotechnology Dec 10, 2017 Enabling global access to high-quality biopharmaceuticals | Current Opinion in Chemical Engineering Oct 22, 2013
Perfusion fermentation in the Daisy Petal™ bioreactor | Sunflower Application Note Jun 13, 2024read more
Alternative hosts as the missing link for equitable therapeutic protein production Mar 11, 2021read more
Expanding access to monoclonal antibody-based products: a global call to action | Wellcome and IAVI Aug 22, 2020read more
The influence of domestic manufacturing capabilities on biologic pricing in emerging economies | Nature Biotechnology May 22, 2019read more
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus May 1, 2021
Development of a platform process for the production and purification of single‐domain antibodies Feb 22, 2021
“Right-sized” efficient multi-product manufacturing | NASEM Workshop on Technical & Regulatory Barriers to Innovations in Pharmaceutical Manufacturing Jun 8, 2020
The yeast stands alone: the future of protein biologic production | Current Opinion in Biotechnology Dec 10, 2017
Enabling global access to high-quality biopharmaceuticals | Current Opinion in Chemical Engineering Oct 22, 2013
